Dapagliflozin initiation in chronic heart failure patients improves central sleep apnoea

Dapagliflozin decreases central sleep apnoea in central sleep apnoea patients, thereby sparing the initiation of ventilatory therapy https://bit.ly/41e2fm0

Detalles Bibliográficos
Autores principales: Jaffuel, Dany, Bouchaut, Yannick, Mallet, Jean-Pierre, Vidal, Célia, Molinari, Nicolas, Bourdin, Arnaud, Roubille, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291304/
https://www.ncbi.nlm.nih.gov/pubmed/37377653
http://dx.doi.org/10.1183/23120541.00123-2023
Descripción
Sumario:Dapagliflozin decreases central sleep apnoea in central sleep apnoea patients, thereby sparing the initiation of ventilatory therapy https://bit.ly/41e2fm0

Ejemplares similares